4//SEC Filing
GRAINGER DAVID J 4
Accession 0001847903-23-000081
CIK 0001847903other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:02 PM ET
Size
11.4 KB
Accession
0001847903-23-000081
Insider Transaction Report
Form 4
GRAINGER DAVID J
Chief Innovation Officer
Transactions
- Tax Payment
Ordinary Shares
2023-03-31$3.90/sh−4,825$18,818→ 976,480 total
Holdings
- 27,500(indirect: See footnote)
Ordinary Shares
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]Held by RxCelerate Limited ("RxCelerate"). The Reporting Person is a member of the board of directors of RxCelerate. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by RxCelerate, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001887115
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:02 PM ET
- Size
- 11.4 KB